Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer

NCT03025477 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer, Epithelial

Interventions

DRUG: CC0 - Carboplatin (IV) - Paclitaxel (IV)
DRUG: CC0 - Cisplatin (IP) - Epirubicin (IV)
DRUG: CC>0 - Carboplatin (IV)- Paclitaxel (IV)
DRUG: CC>0 - Cisplatin (IP/IV)- Epirubicin (IV)

Sponsor

Groupe Hospitalier Diaconesses Croix Saint-Simon

Collaborators

[object Object]